WANG KEVIN has a total of 12 patent applications. It increased the IP activity by 20.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and it methods for management are F1 ONCOLOGY INC, EXUMA BIOTECH CORP and GUANGZHOU ZHAOTAI INVIVO BIOMEDICINE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 3 | |
#3 | Australia | 1 | |
#4 | China | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | IT methods for management | |
#4 | Audio-visual technology | |
#5 | Telecommunications | |
#6 | Computer technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Data processing systems | |
#4 | Therapeutic chemical compounds | |
#5 | Fermentation | |
#6 | Medical preparations | |
#7 | Wireless communication networks | |
#8 | New plants | |
#9 | Special information storage | |
#10 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Wang Kevin | 12 |
#2 | Jiao Shunchang | 6 |
#3 | Li Wen | 4 |
#4 | Ma Jie | 3 |
#5 | Zhou Weibin | 2 |
#6 | Tang Shunxue | 2 |
#7 | Chen Shuyuan | 1 |
#8 | Chen Xue | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019076361A1 | Use of plant as host in expression of canakinumab | |
AU2018338645A1 | Method and system for online auctions | |
WO2018227698A1 | Application of plant as host in expressing vaccine of middle east respiratory syndrome | |
WO2018227686A1 | Application of plant as host in expressing pd-1 antibody and/or pd-l1 antibody | |
US2010038919A1 | PC tray latch |